111 related articles for article (PubMed ID: 38534313)
1. Intravenous MSC-Treatment Improves Impaired Brain Functions in the R6/2 Mouse Model of Huntington's Disease via Recovered Hepatic Pathological Changes.
Yu-Taeger L; El-Ayoubi A; Qi P; Danielyan L; Nguyen HHP
Cells; 2024 Mar; 13(6):. PubMed ID: 38534313
[TBL] [Abstract][Full Text] [Related]
2. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
Dufour BD; McBride JL
Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
[TBL] [Abstract][Full Text] [Related]
3. An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease.
Kong G; Ellul S; Narayana VK; Kanojia K; Ha HTT; Li S; Renoir T; Cao KL; Hannan AJ
Neurobiol Dis; 2021 Jan; 148():105199. PubMed ID: 33249136
[TBL] [Abstract][Full Text] [Related]
4. N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's disease.
Wright DJ; Renoir T; Smith ZM; Frazier AE; Francis PS; Thorburn DR; McGee SL; Hannan AJ; Gray LJ
Transl Psychiatry; 2015 Jan; 5(1):e492. PubMed ID: 25562842
[TBL] [Abstract][Full Text] [Related]
5. A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington's disease.
Chen KP; Hua KF; Tsai FT; Lin TY; Cheng CY; Yang DI; Hsu HT; Ju TC
J Neuroinflammation; 2022 Feb; 19(1):56. PubMed ID: 35219323
[TBL] [Abstract][Full Text] [Related]
6. Treatment with a herbal formula B401 enhances neuroprotection and angiogenesis in the R6/2 mouse model of Huntington's disease.
Wang SE; Lin CL; Hsu CH; Sheu SJ; Chien CT; Wu CH
Drug Des Devel Ther; 2015; 9():887-900. PubMed ID: 25733809
[TBL] [Abstract][Full Text] [Related]
7. Liver integrity and the risk of Alzheimer's disease and related dementias.
Lu Y; Pike JR; Hoogeveen RC; Walker KA; Raffield LM; Selvin E; Avery CL; Engel SM; Mielke MM; Garcia T; Palta P
Alzheimers Dement; 2024 Mar; 20(3):1913-1922. PubMed ID: 38153336
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies.
Zhang X; Tang B; Guo J
Transl Neurodegener; 2023 Dec; 12(1):59. PubMed ID: 38098067
[TBL] [Abstract][Full Text] [Related]
9. Low Alanine Aminotransferase, as a Marker of Sarcopenia and Frailty, Is Associated with Shorter Survival Among Prostate Cancer Patients and Survivors. A Retrospective Cohort Analysis of 4064 Patients.
Laufer M; Perelman M; Sarfaty M; Itelman E; Segal G
Eur Urol Open Sci; 2023 Sep; 55():38-44. PubMed ID: 37693730
[TBL] [Abstract][Full Text] [Related]
10. Huntingtin loss in hepatocytes is associated with altered metabolism, adhesion, and liver zonation.
Bragg RM; Coffey SR; Cantle JP; Hu S; Singh S; Legg SR; McHugh CA; Toor A; Zeitlin SO; Kwak S; Howland D; Vogt TF; Monga SP; Carroll JB
Life Sci Alliance; 2023 Nov; 6(11):. PubMed ID: 37684045
[TBL] [Abstract][Full Text] [Related]
11. Peripheral metabolic alterations associated with pathological manifestations of Parkinson's disease in gut-brain axis-based mouse model.
Huh E; Choi JG; Lee MY; Kim JH; Choi Y; Ju IG; Eo H; Park MG; Kim DH; Park HJ; Lee CH; Oh MS
Front Mol Neurosci; 2023; 16():1201073. PubMed ID: 37635904
[TBL] [Abstract][Full Text] [Related]
12. Alterations of gut microbiota and its correlation with the liver metabolome in the process of ameliorating Parkinson's disease with Buyang Huanwu decoction.
Hu J; Li P; Zhao H; Ji P; Yang Y; Ma J; Zhao X
J Ethnopharmacol; 2024 Jan; 318(Pt A):116893. PubMed ID: 37423520
[TBL] [Abstract][Full Text] [Related]
13. Elevated C-reactive protein mediates the liver-brain axis: a preliminary study.
Jiang R; Wu J; Rosenblatt M; Dai W; Rodriguez RX; Sui J; Qi S; Liang Q; Xu B; Meng Q; Calhoun VD; Scheinost D
EBioMedicine; 2023 Jul; 93():104679. PubMed ID: 37356206
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
